Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-23 Purchase | 2023-06-27 4:11 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 1,470,588 | $3.4 | $4,999,999 | 4,326,435 (Indirect) | View |
| 2022-12-02 Purchase | 2022-12-06 3:19 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) | View |
| 2022-12-02 Sale | 2022-12-06 3:19 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) | View |
| 2022-07-08 Purchase | 2022-07-21 1:06 pm | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB 10% Owner | 207,974 | $1.3266 | $275,898 | 2,855,827 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-07-21 1:03 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB 10% Owner | 0 | $0 | 2,647,873 (Indirect) | View |